BAFF rs9514828 gene polymorphism and the risk of the development of inhibitors in children with severe haemophilia A.

doi:10.1111/hae.14555

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

BAFF rs9514828 gene polymorphism and the risk of the development of inhibitors in children with severe haemophilia A.

Haemophilia : the official journal of the World Federation of Hemophilia - 1 May 2022

Hodeib Hossam, El Amrousy Doaa, Youssef Amira, Elaskary Eman, Fouda Mohamed H

Abstract excerpt

INTRODUCTION: Haemophilia A (HA) is an x-linked recessive disease due to deficiency of coagulation factor VIII (FVIII). The development of neutralizing antibodies (inhibitors) against infused FVIII is a major concern. B cell activating factor (BAFF) has been implicated in several autoimmune diseases. AIM: We aimed to evaluate the possible association of BAFF rs9514828 gene polymorphism and the risk of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to B-Cell Activating Factor

Share to Child

Share to Cohort Studies

Share to Factor VIII

Share to Hemophilia A

Share to Hemostatics

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed

Identifiers

PMID: 35316553
DOI: 10.1111/hae.14555

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BAFF rs9514828 gene polymorphism and the risk of the development of inhibitors in children with severe haemophilia A.PMID 35316553Read ↗

HLA Variants and Inhibitor Development in Hemophilia A: A Retrospective Case-Controlled Study Using the ATHNdatasetSemantic proximity Read ↗

Development of inhibitors in hemophilia A: An illustrated reviewSemantic proximity Read ↗

Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A.Semantic proximity Read ↗

Genetic risk factors for inhibitors in haemophilia A.Semantic proximity Read ↗

Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.Semantic proximity Read ↗

Prevention of inhibitor development in hemophilia A in 2016. A glimpse into the future?Semantic proximity Read ↗

Genetics and Epigenetics in Acquired Hemophilia A: From Bench to BedsideSemantic proximity Read ↗

Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.Semantic proximity Read ↗

Risk factors associated with inhibitor development in Chinese patients with haemophilia B.Semantic proximity Read ↗

Genome-Wide Association Study and Gene-Based Analysis of Participants With Hemophilia A and Inhibitors in the My Life, Our Future Research RepositorySemantic proximity Read ↗

Inhibitor incidence in an unselected cohort of previously untreated patients with severe haemophilia B: a PedNet studySemantic proximity Read ↗

Genetic risk factors for inhibitors to factors VIII and IX.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.